Number of children and risk of Parkinson's disease

Movement Disorders

Volumn 22, Issue 5, 2007, Pages 632-639

  Frigerio, Roberta ^a,c   Breteler, Monique M B ^b   De Lau, Lonneke M L ^b   Sanft, Kevin R ^a   Bower, James H ^a   Ahlskog, J Eric ^a   Grossardt, Brandon R ^a   De Andrade, Mariza ^a   Maraganore, Demetrius M ^a   Rocca, Walter A ^a,d  

^a Mayo Clinic College of Medicine   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d MAYO CLINIC   (United States)

Author keywords

Case control study; Cohort study; Epidemiology; Number of children; Parkinson's disease; Reproductive characteristics

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION DYNAMICS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENTIATION; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-CULTURAL COMPARISON; FAMILY CHARACTERISTICS; FEMALE; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; MINNESOTA; NETHERLANDS; PARKINSON DISEASE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEX FACTORS;

EID: 34249015669     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21341     Document Type: Article

References (34)

1. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-259.
2. Annesi G, Savettieri G, Pugliese P, et al. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann Neurol 2005;58:803-807.
3. Wagenfeld A, Gromoll J, Cooper TG. Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization. Biochem Biophys Res Commun 1998;251:545-549.
4. Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SM, Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx α to the receptor. J Biol Chem 2001;276:37556-37563.
5. Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SM, Ariga H. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res 2003;1:247-261.
6. Maraganore DM, Wilkes K, Lesnick TG, et al. A limited role for DJ1 in Parkinson disease susceptibility. Neurology 2004;63:550-553.
7. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005;77:685-693.
8. Melton LJ, III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
9. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
10. Elbaz A, Peterson BJ, Yang P, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 2002;13: 157-164.
11. Rocca WA, Peterson BJ, McDonnell SK, et al. The Mayo Clinic Family Study of Parkinson's disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005;24:151-167.
12. Frigerio R, Elbaz A, Sanft KR, et al. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 2005;65:1575-1583.
13. Joffe M, Li Z. Male and female factors in fertility. Am J Epidemiol 1994;140:921-929.
14. Peate I. The effects of smoking on the reproductive health of men. Br J Nurs 2005;14:362-366.
15. Aitken RJ, Koopman P, Lewis SE. Seeds of concern. Nature 2004;432:48-52.
16. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000;55:1350-1358.
17. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-422.
18. de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995;45:2143-2146.
19. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004;63: 1240-1244.
20. Fahn S, Elton RL, Committee MoTUD. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan Healthcare Information; 1987. p 153-163.
21. de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam Study. Neurology 2005;64:2040-2045.
22. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. II:The Design and Analysis of Cohort Studies. Lyon: IARC; 1987. p 1-406.
23. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987;44:573-588.
24. Menza MA, Golbe LI, Cody RA, Forman NE. Dopamine-related personality traits in Parkinson's disease. Neurology 1993;43:505-508.
25. Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, de Andrade M, Rocca WA. The Mayo Clinic Cohort Study of personality and aging: results for Parkinson's disease. Neurology 2005;64: A282-A283.
26. Gillies GE, Murray HE, Dexter D, McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol Biochem Behav 2004;78:513-522.
27. Becker JB. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 1999;64: 803-812.
28. Gans S, Erskine MS. Effects of neonatal testosterone treatment on pacing behaviors and development of a conditioned place preference. Horm Behav 2003;44:354-364.
29. Martignoni E, Nappi RE, Citterio A, et al. Reproductive life milestones in women with Parkinson's disease. Funct Neurol 2003; 18:211-217.
30. Pals P, Van Everbroeck B, Grubben B, et al. Case-control study of environmental risk factors for Parkinson's disease in Belgium. Eur J Epidemiol 2003;18:1133-1142.
31. Ragonese P, D'Amelio M, Salemi G, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 2004;62:2010-2014.
32. Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 2003;60:790-795.
33. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 2005;65:383-390.
34. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.